All News

Which Halloween costumes are generating the most buzz this year?

Baloxavir marboxil (Xofluza, Genentech) is the first antiviral medication indicated for patients at high risk of developing influenza-related complications.

Although the demand for pharmacists is expected to increase in a variety of health care settings, the employment of pharmacists in this industry is projected to decline overall in the next 10 years.

Study suggests that blocking a signaling pathway that includes the inflammatory factor CXCL10-CXCR3 may prevent brain metastasis.

Top news of the day from across the health care landscape.

Nine widely-used medications have experienced substantial price growth since 2016, adding $5.1 billion to overall drug spending.

The full-day meeting will feature recognized experts sharing the latest clinical data in oncology, while exploring best practices and management strategies.

Kyowa Kirin’s istradefylline (Nourianz) is now available in the United States as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) that are experiencing “off” episodes.

The International Society of Oncology Pharmacy Practitioners global position on oncology biosimilar use covers regulation and evaluation, implementation, education, and monitoring.

The American College of Obstetricians and Gynecologists has released new guidelines supporting over-the-counter access to hormonal contraception.

Expanded access to direct-acting antiviral drugs are vital to achieve elimination targets set by the World Health Organization for hepatitis C virus infections.

The Pharmacy Technician Certification Board (PTCB) has launched 2 specialty areas of Assessment-Based Certificate Programs: Technician Product Verification (TPV) and Medication History.

Officials from the FDA have approved Noven Pharmaceuticals, Inc.’s asenapine (Secuado) transdermal system, which is the first-and-only transdermal patch for the treatment of adults with schizophrenia, according to the company.

As pharmacists continue to provide more direct patient-centric services, the case for technicians to take on managing pharmacy inventory becomes more reasonable.

Top news of the day from across the health care landscape.

Today is National Pharmacy Technician Day, and pharmacists are sharing how valuable technicians are to them.

In the wake of California’s drug transparency law, an analysis by state health officials on pricing trends found that drug companies raised the whole acquisition cost dramatically for many drugs.

A report by the Institute for Clinical and Economic Review lists the top drugs with the greatest price increases not supported by new clinical evidence.

Researchers at the National Institute of Health (NIH) and the Massachusetts General Hospital in Boston (MGH) found that tesamorelin reduces liver fat and prevents liver fibrosis in people living with HIV.

Why is a 15-year-old boy being prescribed anastrozole?

Measles cases in the United States have reached a record high in 2019, according to a recent CDC report.

A study posted in JAMA Pediatrics evaluated the efficacy and safety of varenicline tartrate for smoking cessation in adolescents and young adults. Compared with the placebo, varenicline tartrate was well-tolerated, but did not improve end-of-treatment abstinence.

New study provides evidence that the use of antiretroviral therapy alters the formation or stabilization of HIV latent reservoirs.

The Rite Aid Foundation is awarding $2.3 million to Children’s Miracle Network Hospitals through its KidCents Grant Program.

Top news of the day from across the health care landscape.

In a Pharmacy Times® Continuing Education Supplement, Leslie J. Vaughan, BS, RPH, examined cost and health care utilization in patients using immunoglobulin agents.

To date, the FDA has granted rivaroxaban 8 indications, 6 of which are specifically for the treatment, prevention, and reduction in the risk of recurrence of venous thromboemolism across a wide range of patient populations.

A researcher at the Washington University School of Medicine in St.Louis has received close to $7.5 million in total funding for research towards development of stem cell-based treatments for chronic pulmonary disease (COPD), asthma, and other disorders.